Heparin - Pluronic F127 nanogel with optimal component ratio for drug delivery applications

424 views

Authors

  • Nguyen Thi Huong (Corresponding Author) Institute of Chemistry and Materials, Academy of Military Science and Technology
  • Nguyen Ngoc Son Institute of Chemistry and Materials, Academy of Military Science and Technology
  • Trinh Dac Hoanh Institute of Chemistry and Materials, Academy of Military Science and Technology
  • Doan Van Phuc Institute of Chemistry and Materials, Academy of Military Science and Technology
  • Dam Thi Vui Thai Nguyen University of Science
  • Nguyen Thi Hai Yen Thai Nguyen University of Science
  • Pham The Chinh Thai Nguyen University of Science

DOI:

https://doi.org/10.54939/1859-1043.j.mst.88.2023.58-65

Keywords:

Heparin; Nanogel; Platin drug; Pluronic F127; Poor water-soluble drug.

Abstract

This study aimed to synthesize a nanogel system based copolymers of Heparin (Hep) and Pluronic F127 (F127) with optimal Hep:F127 ratio for delivering poor water soluble drug and Platinum-based drugss. Firstly, Hep-F127 conjugates were formed via disulfide bridges of cystamine molecules. The obtained Hep-F127 systems were then proved and characterized using Proton nuclear magnetic resonance (1H-NMR), Dynamic Light Scattering (DLS)) methods. Cisplatin (CPT) was used as the Pt drug model, meanwhile Paclitaxel (PTX) was used as poor water-soluble drug model. The encapsulation ability for CPT and PTX was investigated and compared to choose the optimal Hep-F127 ratio. This Hep-F127 nanogel system is expected to be a good carrier for delivering drugs with different properties.

References

[1]. Cerqueira, M.A., et al., "Structural and thermal characterization of galactomannans from non-conventional sources". Carbohydrate polymers, 83(1): p. 179-185, (2011). DOI: https://doi.org/10.1016/j.carbpol.2010.07.036

[2]. Yao, Y., et al., "Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance". Frontiers in molecular biosciences, 7: p. 193. (2020). DOI: https://doi.org/10.3389/fmolb.2020.00193

[3]. Hassanzadeh, P., F. Atyabi, and R. Dinarvand, "The significance of artificial intelligence in drug delivery system design". Advanced drug delivery reviews, 151: p. 169-190. (2019). DOI: https://doi.org/10.1016/j.addr.2019.05.001

[4]. Jarak, I., et al., "Pluronic-based nanovehicles: Recent advances in anticancer therapeutic applications". European Journal of Medicinal Chemistry, 206: p. 112526. (2020). DOI: https://doi.org/10.1016/j.ejmech.2020.112526

[5]. Pitto-Barry, A. and N.P. Barry, "Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances". Polymer Chemistry, 5(10): p. 3291-3297. (2014). DOI: https://doi.org/10.1039/C4PY00039K

[6]. Nguyen, T.T.C., et al., "Highly lipophilic pluronics-conjugated polyamidoamine dendrimer nanocarriers as potential delivery system for hydrophobic drugs". Materials Science and Engineering: C, 70: p. 992-999. (2017). DOI: https://doi.org/10.1016/j.msec.2016.03.073

[7]. Xu, C., B. Wang, and S. Sun, "Dumbbell-like Au− Fe3O4 nanoparticles for target-specific platin delivery". Journal of the American Chemical Society, 131(12): p. 4216-4217. (2009). DOI: https://doi.org/10.1021/ja900790v

[8]. Park, S.S., et al., "Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery". Materials & design, 184: p. 108187. (2019). DOI: https://doi.org/10.1016/j.matdes.2019.108187

[9]. Kemp, M.M. and R.J. Linhardt, "Heparin‐based nanoparticles". Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2(1): p. 77-87. (2010). DOI: https://doi.org/10.1002/wnan.68

[10]. Argyo, C., et al., "Heparin‐Coated Colloidal Mesoporous Silica Nanoparticles Efficiently Bind to Antithrombin as an Anticoagulant Drug‐Delivery System. Chemistry"–A European Journal, 18(2): p. 428-432. (2012). DOI: https://doi.org/10.1002/chem.201102926

[11]. Peng, X.-H., et al., "Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles". Acs Nano, 5(12): p. 9480-9493. (2011). DOI: https://doi.org/10.1021/nn202410f

[12]. Nguyen, N.T., et al., "Synergic activity against MCF-7 breast cancer cell growth of nanocurcumin-encapsulated and cisplatin-complexed nanogels". Molecules, 23(12): p. 3347. (2018). DOI: https://doi.org/10.3390/molecules23123347

[13]. Truong-Thi, N.-H., et al., "pH-Responsive Delivery of Platinum-based Drugs through the Surface Modification of Heparin on Mesoporous Silica Nanoparticles". European Polymer Journal, p. 111818. (2023). DOI: https://doi.org/10.1016/j.eurpolymj.2023.111818

[14]. Golla, E.D. and G.H. Ayres, "Spectrophotometric determination of platinum with o-phenylenediamine". Talanta, 20(2): p. 199-210. (1973). DOI: https://doi.org/10.1016/0039-9140(73)80267-X

[15]. Trang Le, N.T., et al., "Preparation of liposomal nanocarrier by extruder to enhance tumor accumulation of paclitaxel". Journal of Bioactive and Compatible Polymers, 37(1): p. 3-16. (2022). DOI: https://doi.org/10.1177/08839115211053926

[16]. Vu, M.T., et al., "Development and characterization of soy lecithin liposome as potential drug carrier systems for codelivery of letrozole and paclitaxel". Journal of Nanomaterials, p. 1-9. (2020). DOI: https://doi.org/10.1155/2020/8896455

[17]. Vu, M.T., et al., "Development, characterization and in vitro evaluation of paclitaxel and anastrozole Co-loaded liposome". Processes, 8(9): p. 1110. (2020). DOI: https://doi.org/10.3390/pr8091110

[18]. Le, N.T.T., et al., "Methoxy polyethylene glycol–cholesterol modified soy lecithin liposomes for poorly water‐soluble anticancer drug delivery". Journal of Applied Polymer Science, 138(7): p. 49858. (2021). DOI: https://doi.org/10.1002/app.49858

[19]. Shaikhullina, M., et al., "NMR relaxation and self-diffusion in aqueous micellar gels of pluronic F-127". Journal of Molecular Liquids, 306: p. 112898. (2020). DOI: https://doi.org/10.1016/j.molliq.2020.112898

[20]. Choi, J.H., et al., "Self-assembled nanogel of pluronic-conjugated heparin as a versatile drug nanocarrier". Macromolecular research, 19(2): p. 180-188. (2011). DOI: https://doi.org/10.1007/s13233-011-0214-4

[21]. Pomin, V.H., "1H and 15N NMR analyses on heparin, heparan sulfates and related monosaccharides concerning the chemical exchange regime of the N-sulfo-glucosamine sulfamate proton". Pharmaceuticals, 9(3): p. 58. (2016). DOI: https://doi.org/10.3390/ph9030058

[22]. Nguyen, D.H., et al., "Targeting ligand-functionalized and redox-sensitive heparin-Pluronic nanogels for intracellular protein delivery". Biomedical Materials, 6(5): p. 055004. (2011). DOI: https://doi.org/10.1088/1748-6041/6/5/055004

[23]. Mitchell, M.J., et al., "Engineering precision nanoparticles for drug delivery". Nature Reviews Drug Discovery, 20(2): p. 101-124. (2021). DOI: https://doi.org/10.1038/s41573-020-0090-8

[24]. Chen, F., et al., "Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy". Scientific reports, 4(1): p. 1-10. (2014). DOI: https://doi.org/10.1038/srep05080

Downloads

Published

25-06-2023

How to Cite

[1]
D. H. Nguyen Thi, “Heparin - Pluronic F127 nanogel with optimal component ratio for drug delivery applications”, JMST, vol. 88, no. 88, pp. 58–65, Jun. 2023.

Issue

Vol. 88 (2023)

Section

Research Articles

Most read articles by the same author(s)